Your gift will support current research into new agents to treat lung cancer and prevent its recurrence. Memorial Sloan-Kettering researchers are evaluating new drugs for lung cancer, including getifinib (Iressa). First tested at MSKCC, getitinib is one of a new class of drugs known as signal transduction inhibitors, which work by blocking the signal that make cancer cells grow and spread.

Your donation will help put us one step closer to finding a cure for hydrocephalus. Since the government gives almost no funding toward meaningful Hydrocephalus research, hope for a cure has been hard to come by. Most research being done is focused on creating a new type of shunt; since treating a condition is much more profitable than curing one. In the entire United States,...

Your gift will provide much needed hope to patients with brain cancer. You will move this underserved field forward to make a difference by bringing an innovative approach to finding therapies for this devastating disease.

In an effort to quicken the evaluation of therapeutic candidates for possible advancement to the clinic for brain cancer patients, ABC2 partnered with the Preston Robert Tisch Brain Center at Duke University to form the Preclinical Screening Program. Your gift will support a critical link with the biopharmaceutical industry and academia and help fill a void in the drug development arena by providing a venue...

Your investment will help attract the best and brightest researchers to the field of brain cancer. Young Investigator Awards encourage and invest in physician-scientists who are building their careers in translational medicine. The awards provide support for a three-year period in neuro-oncology and address key scientific and medical challenges in the development of effective brain cancer therapies.

Your contribution will support the important work of your favorite Medical Research Nonprofit and help make the world a better place.

Your gift of $1,200 provides one week in the lab for an AFAR researcher conducting ground-breaking research on aging and age-related diseases, including cancer, heart disease, Alzheimer's disease, and osteoporosis. AFAR grants scientists -- after they have passed a rigorous review process -- $60,000 to study a broad range of topics, including the causes of cellular senescence, the role of estrogen in the development of...

Your gift of $960 provides days in the lab for an AFAR researcher conducting ground-breaking research on aging and age-related diseases, including cancer, heart disease, Alzheimer's disease, and osteoporosis. AFAR grants scientists -- after they have passed a rigorous review process -- $60,000 to study a broad range of topics, including the causes of cellular senescence, the role of estrogen in the development of osteoporosis,...

Your gift of $720 provides three days in the lab for an AFAR researcher conducting ground-breaking research on aging and age-related diseases, including cancer, heart disease, Alzheimer's disease, and osteoporosis. AFAR grants scientists -- after they have passed a rigorous review process -- $60,000 to study a broad range of topics, including the causes of cellular senescence, the role of estrogen in the development of...

Your gift of $480 provides two days of work in the lab for an AFAR researcher conducting ground-breaking research on aging and age-related diseases, including cancer, heart disease, Alzheimer's disease, and osteoporosis. AFAR grants scientists -- after they have passed a rigorous review process -- $60,000 to study a broad range of topics, including the causes of cellular senescence, the role of estrogen in the...

Your gift of $240 provides one day in the lab for an AFAR researcher conducting ground-breaking research on aging and age-related diseases, including cancer, heart disease, Alzheimer's disease, and osteoporosis. AFAR grants scientists -- after they have passed a rigorous review process -- $60,000 to study a broad range of topics, including the causes of cellular senescence, the role of estrogen in the development of...

Your gift of $120 provides one half day in the lab for an AFAR researcher conducting ground-breaking research on aging and age-related diseases, including cancer, heart disease, Alzheimer's disease, and osteoporosis. AFAR grants scientists -- after they have passed a rigorous review process -- $60,000 to study a broad range of topics, including the causes of cellular senescence, the role of estrogen in the development...

This gift will support vital PKD research funding aimed at finding a treatment and cure for PKD.

Your gift of $30 provides one hour of time in the lab for an AFAR researcher conducting ground-breaking research on aging and age-related diseases, including cancer, heart disease, Alzheimer's disease, and osteoporosis. AFAR grants scientists -- after they have passed a rigorous review process -- $60,000 to study a broad range of topics, including the causes of cellular senescence, the role of estrogen in the...

This gift will support one legislative appointment to advocate on behalf of the PKD Foundation.

There are new technologies through which we are developing an understanding of genes proteins and networks – offering the possibility to shift from a one-size fits all model. Your gift will help accelerate a cure for brain cancer through supporting pioneering innovation and technology to find the right therapy for the right patient at the right time. This approach will redefine the nature of the...

This gift will provide a one year subscription, of this valuable publication, for someone who does not otherwise have the means to subscribe.

Your gift will fund 15 minutes of vital PKD Research. PKD scientists funded by the PKD Foundation have progressed from discovering the PKD genes to conducting clinical trials in humans - an unprecedented level of biomedical research success. You can be a part of this success! Join our quest to find a treatment for PKD!

This gift will support vital PKD research funding aimed at finding a treatment and cure for PKD.

Accelerate Brain Cancer Cure brings together researchers, clinicians, the biotech and pharmaceutical industry and government to fund research that translates promising laboratory successes into clinically meaningful improvements for patients. This approach is designed to provide innovative researchers with the support required to make critical translational breakthroughs. Accelerate Brain Cancer Cure fund proposals that will have an immediate impact, and we work actively and partner with...